Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Jan 20 2000
CEO & Investor Conference To Showcase Industry To New Investors WASHINGTON, D.C. (January 20, 2000) Recent gains inbiotechnology stocks have rivaled the...
Jan 18 2000
WASHINGTON, D.C. (January 14, 2000) A BIO-sponsored television ad will begin running Jan. 17 on cable and news talk shows throughout the Washington...
Jan 18 2000
WASHINGTON, D.C. (Jan. 18, 2000) Another 22biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug...
Jan 11 2000
Washington, D.C. (January 11, 2000) The Biotechnology Industry Organization (BIO) will host its 14th International Biotechnology Meeting and Exhibition two...
Dec 20 1999
WASHINGTON, D.C. (Dec. 20, 1999) -- Dr. Judah Folkman, who discovered the process of tumor angiogenesis, and Dr. Jurgen Drews, former president of global...
Dec 7 1999
WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient...
Dec 6 1999
(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech): Washington, D.C. (December 6,...
Nov 24 1999
(Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement prior to the start of the World Trade Organization's...
Nov 23 1999
See Senate Resolution 200 below WASHINGTON, D.C. (Nov. 23, 1999) -- The Biotechnology Industry Organization (BIO) applauds the U.S. Senate for its adoption of...


Biotechnology News

August 22, 2014

--(BUSINESS WIRE)--Nanotherapeutics, Inc. (www.nanotherapeutics.com) is a privately held...

August 22, 2014

SEATTLE--(BUSINESS WIRE)--Seattle BioMed announced today its founder, Ken Stuart, Ph.D., has been presented with the Award for Impact by the Washington Global Health...

August 22, 2014

STOCKHOLM--(BUSINESS WIRE)--Elekta (STO:EKTAB) Elekta welcomes you to its Capital Markets Day on September 15, in conjunction with the 56th Annual Meeting of the American...

August 22, 2014

LOS ANGELES--(BUSINESS WIRE)--The board of directors of Bud Genius (Symbol: RIGH) yesterday began discussion on filing an S-1 registration for its new subsidiary, Genius...

August 22, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife AB (STO:VITR) has terminated its market maker agreement with Remium due to the increased share trading. The...